Intricon Stock

Intricon ROE

Delisted

The Return on Equity (ROE) of Intricon (IIN) as of Sep 10, 2026 is -0.11 %. In the previous year, Return on Equity (ROE) was -2.77 % — a change of -95.91% (higher).

ROE

-0.11 %

YoY

-95.91%

Last updated:

In 2026, Intricon's return on equity (ROE) was -0.11 %, a -95.91% increase from the -2.77 % ROE in the previous year.

The Intricon ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2014
13.96 USD
Jan 1, 2015
11.79 USD
Jan 1, 2016
-24.72 USD
Jan 1, 2017
8.62 USD
Jan 1, 2018
6.01 USD
Jan 1, 2019
-4.16 USD
Jan 1, 2020
-2.77 USD
Jan 1, 2021
-0.11 USD
The Intricon ROE history
YEARROEYoY
-0.11 %-95.91%
-2.77 %-33.48%
-4.16 %-169.20%
6.01 %-30.19%
8.62 %-134.85%
-24.72 %-309.66%
11.79 %-15.52%
13.96 %
Access this data via the Eulerpool API

Intricon Stock analysis

What does Intricon do? IntriCon Corp is a leading global provider of microelectronic components and solutions for various industries such as medical, energy, audio, communication, and security. The company was founded in 1930 as Intricate Assemblies and is headquartered in Arden Hills, Minnesota, USA. IntriCon has been listed on the NASDAQ stock exchange since 1967. IntriCon is known for its innovative solutions that enable customers to improve the performance and efficiency of their products. The company has extensive manufacturing capabilities in various parts of the world, including the USA, Singapore, Indonesia, and China. IntriCon's business model is based on a custom product range tailored to the specific requirements of industries. IntriCon specializes in developing custom solutions for complex technological problems. The company heavily invests in research and development to find innovative solutions for customers. IntriCon works closely with its customers to ensure that the solutions meet the requirements. IntriCon Corp offers its services in two main business areas: Medical/Healthcare and Hearing Health. In the Medical/Healthcare sector, the company specializes in the development and manufacturing of microelectronic components for medical applications. IntriCon offers its customers a wide range of products, including wireless communication and monitoring systems for patients, hearing aids, implantable medical devices, and high-precision sensors for medical instruments. In the Hearing Health sector, IntriCon specializes in the development and manufacturing of hearing aids and wireless communication systems. IntriCon develops innovative hearing aid technologies that allow customers to achieve higher sound quality and better amplification options. The company also offers wireless communication systems that enable customers to communicate wirelessly with other devices. IntriCon Corp is known for its ability to develop custom solutions for complex technological problems. The company is able to quickly adapt production capacity to respond to changing market demands. The company is also committed to continuously improving the quality of its products to ensure they meet the requirements of its customers. In addition to its main business areas, IntriCon also offers engineering services focused on developing custom solutions. The company leverages its extensive technical expertise to assist customers in developing innovative products, systems, and components. Overall, IntriCon Corp is a leading provider of microelectronic components and solutions for various industries. The company specializes in custom solutions and has extensive manufacturing capabilities in various parts of the world. IntriCon heavily invests in research and development to find innovative solutions for customers. IntriCon is known for its ability to develop custom solutions for complex technological problems and is committed to continuously improving the quality of its products. Intricon is one of the most popular companies on Eulerpool.

ROE Details

Decoding Intricon's Return on Equity (ROE)

Intricon's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Intricon's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Intricon's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Intricon’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Intricon stock

Return on Equity (ROE) of Intricon is -0.11 % in 2026.

Return on Equity (ROE) of Intricon changed from -2.77 % to -0.11 %, representing a -95.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Intricon since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Intricon with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Intricon

All Key Metrics — Intricon